The modified LSD, which they named JRT, did just that—and more. It stimulated neurons to sprout new dendritic branches and ...

Study suggests accelerated brain ageing is a factor in the development of schizophrenia – and can be measured using a simple ...

In April, the American Psychiatric Association (APA) released a comprehensive treatment guideline for treating adults who have been diagnosed with schizophrenia. Titled "The Practice Guideline for ...

Relatively recently, it has become apparent that a small but meaningful proportion of schizophrenic patients experience paniclike symptoms as a component of their condition. The full set of ...

a group with a dual pathology of schizophrenia with cannabis abuse, and a control group of individuals with neither a psychiatric disorder nor drug use," explained Dr. Urigüen. In the study they ...

Synaptic dysfunction is a core component of the pathophysiology of schizophrenia. However, the genetic risk factors and molecular mechanisms related to synaptic dysfunction are still not fully ...

Schizophrenia results from a combination of genetic factors, certain hereditary risks, and a complex pathology affecting different brain regions, neural pathways, neurochemistries, and cell ...

Enrollment for the Phase II trial follows FDA clearance of SPG302 Investigational New Drug application for schizophrenia.

the research group compared the fatty acid content in the blood of samples taken from "a group of individuals with schizophrenia who did not use cannabis, a group who used cannabis and have developed ...

"These findings reinforce the hypothesis that schizophrenia and other disorders ... where and when each genetic factor acts in pathology, since this could impact therapeutic decision-making.

The study results indicate that schizophrenia, bipolar disorder ... of understanding where and when each genetic factor acts in pathology, since this could impact therapeutic decision-making.